| C054919 | 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene | "[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRA mRNA" | 19422813 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA" | 25510870 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PDGFRA mRNA" | 25614096 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA" | 25510870 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in decreased expression of PDGFRA mRNA" | 20406850 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PDGFRA mRNA" | 28973690 |
| C583074 | 4,4'-hexafluorisopropylidene diphenol | "4,4'-hexafluorisopropylidene diphenol results in decreased expression of PDGFRA mRNA" | 25912373 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C029370 | 4-toluidine | 4-toluidine results in decreased expression of PDGFRA mRNA | 27638505 |
| C012606 | 4-vinyl-1-cyclohexene dioxide | 4-vinyl-1-cyclohexene dioxide affects the expression of PDGFRA mRNA | 20829426 |
| C561052 | 5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one | "5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one results in decreased activity of PDGFRA protein" | 21608528 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C106250 | 6,7-dimethoxy-3-phenylquinoxaline | "6,7-dimethoxy-3-phenylquinoxaline inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of PDGFRA protein]" | 26385185 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of PDGFRA mRNA | 17562736 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of PDGFRA mRNA | 28943387 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of PDGFRA gene | 27153756 |
| D000452 | Aldrin | "[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRA mRNA" | 19422813 |
| D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of PDGFRA mRNA | 28522335 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PDGFRA mRNA | 16483693 |
| D001151 | Arsenic | Arsenic results in increased methylation of PDGFRA promoter | 21291286 |
| C015001 | arsenite | arsenite results in increased methylation of PDGFRA promoter | 23974009 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased methylation of PDGFRA promoter | 28329817 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PDGFRA mRNA | 22316170 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PDGFRA mRNA | 22610609 |
| D004958 | Estradiol | Estradiol affects the expression of PDGFRA mRNA | 15598610 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone co-treated with Cuprizone] results in increased expression of PDGFRA mRNA | 19031445 |
| D004958 | Estradiol | Estradiol results in increased expression of PDGFRA mRNA | 19484750 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in decreased expression of PDGFRA mRNA | 25912373 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PDGFRA mRNA | 29275510 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDGFRA mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A affects the expression of PDGFRA mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PDGFRA mRNA | 25084756 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PDGFRA protein | 25084756 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PDGFRA mRNA | 12604637 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PDGFRA protein | 12604637 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PDGFRA mRNA | 28628672 |
| D002104 | Cadmium | Cadmium results in increased phosphorylation of PDGFRA protein | 17125913 |
| D002104 | Cadmium | fulvestrant inhibits the reaction [Cadmium results in increased phosphorylation of PDGFRA protein] | 17125913 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of PDGFRA protein | 17125913 |
| D019256 | Cadmium Chloride | fulvestrant inhibits the reaction [Cadmium Chloride results in increased phosphorylation of PDGFRA protein] | 17125913 |
| D019256 | Cadmium Chloride | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PDGFRA mRNA | 19840844 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of PDGFRA mRNA | 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of PDGFRA mRNA | 16239168 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDGFRA mRNA | 20548288|2093899 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of PDGFRA mRNA | 28472532 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in decreased expression of PDGFRA mRNA | 20971185 |
| D003375 | Coumestrol | Coumestrol results in increased expression of PDGFRA mRNA | 12604637 |
| D003375 | Coumestrol | Coumestrol results in increased expression of PDGFRA protein | 12604637 |
| C461979 | CT52923 | CT52923 binds to and results in decreased activity of PDGFRA protein | 15994924 |
| D003471 | Cuprizone | [Estradiol co-treated with Progesterone co-treated with Cuprizone] results in increased expression of PDGFRA mRNA | 19031445 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of PDGFRA mRNA | 17654400 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of PDGFRA mRNA | 27989131 |
| C515055 | darinaparsin | darinaparsin results in increased expression of PDGFRA mRNA | 22535156 |
| D000069439 | Dasatinib | Dasatinib results in decreased phosphorylation of PDGFRA protein mutant form | 18619723 |
| C014347 | decitabine | decitabine affects the expression of PDGFRA mRNA | 23300844 |
| D003871 | Dermatan Sulfate | Dermatan Sulfate results in decreased expression of PDGFRA mRNA | 16945567 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PDGFRA mRNA] | 27941970 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDGFRA mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PDGFRA mRNA | 28628672 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of PDGFRA mRNA | 22733784 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of PDGFRA mRNA | 21266533 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of PDGFRA mRNA | 24893172 |
| D002945 | Cisplatin | Cisplatin affects the expression of PDGFRA mRNA | 23300844 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of PDGFRA mRNA | 21151649 |
| D003632 | Dichlorodiphenyldichloroethane | "[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRA mRNA" | 19422813 |
| D003633 | Dichlorodiphenyl Dichloroethylene | "[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRA mRNA" | 19422813 |
| D004026 | Dieldrin | "[Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of PDGFRA mRNA" | 19422813 |
| D004041 | Dietary Fats | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PDGFRA mRNA | 27070252 |
| D004041 | Dietary Fats | resveratrol inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PDGFRA mRNA] | 27070252 |
| D019422 | Dietary Sucrose | [Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PDGFRA mRNA | 27070252 |
| D019422 | Dietary Sucrose | resveratrol inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PDGFRA mRNA] | 27070252 |
| D004051 | Diethylhexyl Phthalate | [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of PDGFRA mRNA | 25031359 |
| D004051 | Diethylhexyl Phthalate | [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of PDGFRA protein | 25031359 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of PDGFRA mRNA | 25031359 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of PDGFRA protein | 25031359 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of PDGFRA mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of PDGFRA mRNA | 24535843 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of PDGFRA mRNA | 12604637 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of PDGFRA protein | 12604637 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of PDGFRA mRNA | 25380136 |
| D004147 | Dioxins | Dioxins affects the expression of PDGFRA mRNA | 20463971 |
| D004221 | Disulfiram | Disulfiram results in decreased expression of PDGFRA mRNA | 20530235 |
| D004237 | Diuron | Diuron results in decreased expression of PDGFRA mRNA | 25152437 |
| D004237 | Diuron | Diuron results in increased expression of PDGFRA mRNA | 21551480 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of PDGFRA mRNA | 17557909 |
| C024565 | ethylene dichloride | ethylene dichloride results in increased expression of PDGFRA mRNA | 28189721 |
| D005485 | Flutamide | Flutamide results in decreased expression of PDGFRA mRNA | 21126777 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDGFRA mRNA | 20548288|2093899 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of PDGFRA mRNA | 18045764 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of PDGFRA mRNA | 18045764 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Cadmium Chloride results in increased phosphorylation of PDGFRA protein] | 17125913 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Cadmium results in increased phosphorylation of PDGFRA protein] | 17125913 |
| C039281 | furan | furan results in decreased methylation of PDGFRA gene | 27387713 |
| C039281 | furan | furan results in increased expression of PDGFRA mRNA | 27387713 |
| D005665 | Furosemide | Furosemide affects the expression of PDGFRA mRNA | 16526316 |
| D019833 | Genistein | Genistein results in decreased expression of PDGFRA mRNA | 22228119 |
| D019833 | Genistein | [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of PDGFRA mRNA | 25031359 |
| D019833 | Genistein | [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of PDGFRA protein | 25031359 |
| D019833 | Genistein | Genistein results in decreased expression of PDGFRA mRNA | 25031359 |
| D019833 | Genistein | Genistein results in decreased expression of PDGFRA protein | 25031359 |
| D019833 | Genistein | Genistein results in increased expression of PDGFRA mRNA | 12604637 |
| D019833 | Genistein | Genistein results in increased expression of PDGFRA protein | 12604637 |
| D005947 | Glucose | [INS protein co-treated with Glucose] results in increased expression of PDGFRA mRNA | 22634610 |
| C010176 | halofuginone | halofuginone results in increased expression of PDGFRA mRNA | 17180598 |
| D006493 | Heparin | Heparin results in decreased expression of PDGFRA mRNA | 16945567 |
| C538724 | HhAntag691 | [GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of PDGFRA protein] | 22087285 |
| C538724 | HhAntag691 | HhAntag691 results in decreased expression of PDGFRA protein | 22087285 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of PDGFRA mRNA | 17997286 |
| D006861 | Hydrogen Peroxide | Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of PDGFRA mRNA] | 17997286 |
| D006861 | Hydrogen Peroxide | [nitrofen results in increased expression of [PDGFA protein co-treated with PDGFRA protein]] which results in increased abundance of Hydrogen Peroxide | 20920717 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in decreased expression of PDGFRA protein | 15786421|1761435 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in decreased expression of PDGFRA protein modified form | 17614352 |
| D000068877 | Imatinib Mesylate | Progesterone promotes the reaction [Imatinib Mesylate results in decreased expression of PDGFRA protein] | 17614352 |
| D000068877 | Imatinib Mesylate | Progesterone promotes the reaction [Imatinib Mesylate results in decreased expression of PDGFRA protein modified form] | 17614352 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in decreased expression of PDGFRA protein | 22447953 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDGFRA mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PDGFRA mRNA | 28628672 |
| D007213 | Indomethacin | Indomethacin results in increased expression of PDGFRA mRNA | 17440234 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDGFRA mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PDGFRA mRNA | 28628672 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of PDGFRA mRNA | 25961927 |
| D007854 | Lead | CBL protein affects the reaction [Lead results in decreased expression of PDGFRA protein] | 17298174 |
| D007854 | Lead | FYN protein affects the reaction [Lead results in decreased expression of PDGFRA protein] | 17298174 |
| D007854 | Lead | Lead results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of PDGFRA protein | 17298174 |
| C008261 | lead acetate | CBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein] | 17298174 |
| C008261 | lead acetate | FYN protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein] | 17298174 |
| C008261 | lead acetate | lead acetate results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of PDGFRA protein | 17298174 |
| C045463 | leflunomide | leflunomide results in increased expression of PDGFRA mRNA | 24136188 |
| D008148 | Lovastatin | Lovastatin results in decreased expression of PDGFRA mRNA | 20578043 |
| D008344 | Maneb | [Maneb co-treated with Paraquat] results in increased expression of PDGFRA mRNA | 23963992 |
| D008344 | Maneb | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of PDGFRA mRNA] | 23963992 |
| D008550 | Melatonin | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of PDGFRA mRNA] | 23963992 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of PDGFRA mRNA | 28619521 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PDGFRA mRNA | 20548288|2093899 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of PDGFRA protein | 17298174 |
| D008767 | Methylmercury Compounds | CBL protein affects the reaction [Methylmercury Compounds results in increased ubiquitination of and results in increased degradation of PDGFRA protein] | 17298174 |
| D008767 | Methylmercury Compounds | FYN protein affects the reaction [Methylmercury Compounds results in increased ubiquitination of and results in increased degradation of PDGFRA protein] | 17298174 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of PDGFRA protein | 17298174 |
| D008767 | Methylmercury Compounds | Methylmercury Compounds results in increased ubiquitination of and results in increased degradation of PDGFRA protein | 17298174 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of PDGFRA mRNA | 26011545 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PDGFRA mRNA" | 26251327 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of PDGFRA mRNA | 19840844 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PDGFRA mRNA | 19840844 |
| D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PDGFRA mRNA | 19840844 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of PDGFRA mRNA | 25972201 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of PDGFRA mRNA | 22108045|2517754 |
| C523799 | MRK 003 | MRK 003 results in decreased expression of PDGFRA mRNA | 21169257 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of PDGFRA mRNA | 18988085 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of PDGFRA mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of PDGFRA mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of PDGFRA mRNA | 25380136 |
| C017096 | n-butoxyethanol | n-butoxyethanol results in decreased expression of PDGFRA mRNA | 19812364 |
| C007350 | nitrofen | [nitrofen results in increased expression of [PDGFA protein co-treated with PDGFRA protein]] which results in increased abundance of Hydrogen Peroxide | 20920717 |
| C007350 | nitrofen | nitrofen results in increased expression of PDGFRA mRNA | 20920717 |
| C007350 | nitrofen | nitrofen results in increased expression of PDGFRA protein | 20920717 |
| C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PDGFRA mRNA | 27935865 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in decreased expression of PDGFRA mRNA | 20971185 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of PDGFRA mRNA | 21703336 |
| C025589 | ochratoxin A | SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of PDGFRA mRNA] | 21703336 |
| D019319 | Okadaic Acid | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of PDGFRA mRNA | 19840844 |
| D010098 | Oxycodone | Oxycodone results in increased expression of PDGFRA protein | 26377394 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of PDGFRA mRNA | 24205000 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of PDGFRA mRNA | 26476374 |
| D010100 | Oxygen | Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of PDGFRA mRNA] | 26476374 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of PDGFRA mRNA | 26272509 |
| D010269 | Paraquat | [Maneb co-treated with Paraquat] results in increased expression of PDGFRA mRNA | 23963992 |
| D010269 | Paraquat | Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of PDGFRA mRNA] | 23963992 |
| D010269 | Paraquat | Paraquat results in increased expression of PDGFRA mRNA | 21371552 |
| D010269 | Paraquat | Paraquat results in increased expression of PDGFRA mRNA alternative form | 17215068 |
| D010269 | Paraquat | CBL protein affects the reaction [Paraquat results in decreased expression of PDGFRA protein] | 17298174 |
| D010269 | Paraquat | FYN protein affects the reaction [Paraquat results in decreased expression of PDGFRA protein] | 17298174 |
| D010269 | Paraquat | Paraquat affects the expression of PDGFRA mRNA | 16854511 |
| D010269 | Paraquat | Paraquat results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of PDGFRA protein | 17298174 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of PDGFRA mRNA | 17987463 |
| D052638 | Particulate Matter | [PDGFRA gene mutant form affects the susceptibility to Particulate Matter] which results in decreased expression of PDGFRA mRNA | 21222557|2122255 |
| C516667 | pazopanib | pazopanib results in decreased activity of PDGFRA protein | 19956806|2061637 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PDGFRA mRNA" | 25510870 |
| C046012 | pentanal | pentanal results in increased expression of PDGFRA mRNA | 26079696 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of PDGFRA mRNA | 19162173 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of PDGFRA mRNA | 24535843 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of PDGFRA mRNA | 23091169 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of PDGFRA mRNA | 26272509 |
| D010671 | Phenylurea Compounds | Phenylurea Compounds results in decreased activity of PDGFRA protein | 18343900 |
| C060836 | pioglitazone | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PDGFRA mRNA | 27935865 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PDGFRA mRNA | 19710929 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of PDGFRA mRNA | 12832660 |
| C545373 | ponatinib | ponatinib analog results in decreased activity of PDGFRA protein | 21561767 |
| C545373 | ponatinib | ponatinib results in decreased activity of PDGFRA protein | 19878872 |
| C545373 | ponatinib | ponatinib results in decreased activity of PDGFRA protein mutant form | 19878872 |
| C545373 | ponatinib | ponatinib results in decreased phosphorylation of PDGFRA protein mutant form | 21482694 |
| C545373 | ponatinib | ponatinib affects the activity of PDGFRA protein mutant form | 22301675 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of PDGFRA mRNA | 23608068 |
| D011374 | Progesterone | Progesterone promotes the reaction [Imatinib Mesylate results in decreased expression of PDGFRA protein] | 17614352 |
| D011374 | Progesterone | Progesterone promotes the reaction [Imatinib Mesylate results in decreased expression of PDGFRA protein modified form] | 17614352 |
| D011374 | Progesterone | [Progesterone results in increased secretion of [VEGFA protein binds to VEGFA protein]] which results in increased phosphorylation of PDGFRA protein | 16888808 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone co-treated with Cuprizone] results in increased expression of PDGFRA mRNA | 19031445 |
| D011374 | Progesterone | Progesterone results in increased expression of PDGFRA mRNA | 22238285 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of PDGFRA mRNA | 26079696 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of PDGFRA mRNA | 24780913 |
| D047428 | Protein Kinase Inhibitors | Protein Kinase Inhibitors inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of PDGFRA protein] | 26385185 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of PDGFRA mRNA] | 26476374 |
| D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of PDGFRA mRNA | 14699072 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PDGFRA mRNA] | 27070252 |
| D017632 | Asbestos, Serpentine | "Asbestos, Serpentine results in decreased expression of PDGFRA mRNA" | 16251409 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of PDGFRA mRNA | 25895662 |
| D012834 | Silver | Silver results in decreased expression of PDGFRA mRNA | 27131904 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of PDGFRA mRNA | 16414398 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of PDGFRA mRNA | 21795629 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of PDGFRA mRNA | 23634900 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in decreased expression of PDGFRA mRNA] | 17997286 |
| D018038 | Sodium Selenite | Sodium Selenite results in decreased expression of PDGFRA mRNA | 18209489 |
| C471405 | sorafenib | sorafenib results in decreased phosphorylation of PDGFRA protein mutant form | 21482694 |
| D013311 | Streptozocin | Streptozocin results in decreased expression of PDGFRA mRNA | 26073000 |
| C473478 | sunitinib | sunitinib results in decreased phosphorylation of PDGFRA protein mutant form | 21482694 |
| C473478 | sunitinib | sunitinib results in decreased activity of PDGFRA protein | 20616376 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of PDGFRA mRNA | 24769059 |
| D013749 | Tetrachlorodibenzodioxin | SRC protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PDGFRA mRNA] | 14708085 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PDGFRA mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PDGFRA mRNA | 14708085|1758670 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PDGFRA mRNA | 22298810 |
| D013755 | Tetradecanoylphorbol Acetate | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of PDGFRA mRNA | 19840844 |
| D019284 | Thapsigargin | Thapsigargin results in decreased expression of PDGFRA mRNA | 22378314 |
| D013893 | Thiram | Thiram results in decreased expression of PDGFRA mRNA | 20530235 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of PDGFRA mRNA | 23557971 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of PDGFRA mRNA | 20133372 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of PDGFRA mRNA" | 19682533 |
| C496197 | trans-10,cis-12-conjugated linoleic acid | "trans-10,cis-12-conjugated linoleic acid results in decreased expression of PDGFRA mRNA" | 17951470 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PDGFRA mRNA | 21934132|2372400 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PDGFRA protein | 16956736 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PDGFRA mRNA | 16604517 |
| C447082 | tricarbonyldichlororuthenium (II) dimer | "6,7-dimethoxy-3-phenylquinoxaline inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of PDGFRA protein]" | 26385185 |
| C447082 | tricarbonyldichlororuthenium (II) dimer | Protein Kinase Inhibitors inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of PDGFRA protein] | 26385185 |
| C447082 | tricarbonyldichlororuthenium (II) dimer | tricarbonyldichlororuthenium (II) dimer inhibits the reaction [F2 protein results in increased phosphorylation of PDGFRA protein] | 26385185 |
| C447082 | tricarbonyldichlororuthenium (II) dimer | tricarbonyldichlororuthenium (II) dimer promotes the reaction [PDGFRA protein binds to PTK2B protein] | 26385185 |
| C447082 | tricarbonyldichlororuthenium (II) dimer | tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of PDGFRA protein | 26385185 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of PDGFRA mRNA | 24935251|2627250 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of PDGFRA mRNA | 15901671 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of PDGFRA mRNA | 22378314 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of PDGFRA mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PDGFRA mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PDGFRA mRNA | 19136453|2489608 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of PDGFRA mRNA | 15901671 |
| C066075 | vanadium pentoxide | vanadium pentoxide results in increased expression of PDGFRA mRNA | 17134509 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of PDGFRA mRNA | 17987463 |
| D001335 | Vehicle Emissions | [PDGFRA gene mutant form affects the susceptibility to Vehicle Emissions] which results in decreased expression of PDGFRA mRNA | 21222557|2122255 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of PDGFRA gene | 25560391 |
| C025643 | vinclozolin | vinclozolin results in increased expression of PDGFRA mRNA | 23034163 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of PDGFRA mRNA | 26682919 |
| D014810 | Vitamin E | Vitamin E results in increased expression of PDGFRA mRNA | 19244175 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDGFRA mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of PDGFRA mRNA | 26272509 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of PDGFRA mRNA | 24714768 |